Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+
antibiotics Archive
-
![QP42 is the lead compound in its class, a novel anti-TB compound with a novel mechanism of action. The molecule is being developed by Quantum and is currently in preclinical [...]](http://q-pharm.com/wp-content/uploads/2010/12/chart_7.png "QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates)")
QP42 in-vitro efficacy summary (MDR, XDR strains, other drugs/drug candidates)
Posted on December 21, 2010 | No CommentsQP42 is the lead compound in its class, a novel anti-TB compound with a novel mechanism of action. The molecule is being developed by Quantum and is currently in preclinical [...] -
![Recently, RecA has established itself as a potential target for the development of antibacterial drugs. The dual function of recA allows bacteria both to control the damage associated with the [...]](http://q-pharm.com/wp-content/uploads/2010/07/recAhits.png "New inhibitors of RecA (bacterial SOS response system) identified.")
New inhibitors of RecA (bacterial SOS response system) identified.
Posted on July 14, 2010 | 2 CommentsRecently, RecA has established itself as a potential target for the development of antibacterial drugs. The dual function of recA allows bacteria both to control the damage associated with the [...]